nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—stomach cancer	0.557	0.774	CbGaD
Tolmetin—PTGS2—stomach cancer	0.162	0.226	CbGaD
Tolmetin—MPO—blood vessel—stomach cancer	0.00346	0.0716	CbGeAlD
Tolmetin—TDO2—endocrine gland—stomach cancer	0.00329	0.0681	CbGeAlD
Tolmetin—TDO2—liver—stomach cancer	0.00297	0.0614	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—stomach cancer	0.00278	0.0575	CbGeAlD
Tolmetin—CXCL8—pancreas—stomach cancer	0.00257	0.0531	CbGeAlD
Tolmetin—TDO2—lymph node—stomach cancer	0.00227	0.0471	CbGeAlD
Tolmetin—CXCL8—bone marrow—stomach cancer	0.00202	0.0418	CbGeAlD
Tolmetin—MPO—hematopoietic system—stomach cancer	0.00184	0.0381	CbGeAlD
Tolmetin—MPO—epithelium—stomach cancer	0.00169	0.0349	CbGeAlD
Tolmetin—PTGS1—blood vessel—stomach cancer	0.00164	0.034	CbGeAlD
Tolmetin—CXCL8—liver—stomach cancer	0.00163	0.0338	CbGeAlD
Tolmetin—PTGS2—blood vessel—stomach cancer	0.00157	0.0325	CbGeAlD
Tolmetin—MPO—pancreas—stomach cancer	0.0015	0.0311	CbGeAlD
Tolmetin—PTGS2—gall bladder—stomach cancer	0.00148	0.0306	CbGeAlD
Tolmetin—MPO—lymphoid tissue—stomach cancer	0.0013	0.0269	CbGeAlD
Tolmetin—Renal failure—Mitomycin—stomach cancer	0.00129	0.0122	CcSEcCtD
Tolmetin—MPO—digestive system—stomach cancer	0.00128	0.0265	CbGeAlD
Tolmetin—Stomatitis—Mitomycin—stomach cancer	0.00128	0.0121	CcSEcCtD
Tolmetin—CXCL8—lymph node—stomach cancer	0.00125	0.0259	CbGeAlD
Tolmetin—MPO—bone marrow—stomach cancer	0.00118	0.0244	CbGeAlD
Tolmetin—Indomethacin—AKR1C3—stomach cancer	0.00109	0.239	CrCbGaD
Tolmetin—Anaphylactic shock—Floxuridine—stomach cancer	0.00107	0.0101	CcSEcCtD
Tolmetin—MPO—endocrine gland—stomach cancer	0.00106	0.0219	CbGeAlD
Tolmetin—Thrombocytopenia—Floxuridine—stomach cancer	0.00104	0.00987	CcSEcCtD
Tolmetin—MPO—liver—stomach cancer	0.000955	0.0198	CbGeAlD
Tolmetin—PTGS1—hematopoietic system—stomach cancer	0.000875	0.0181	CbGeAlD
Tolmetin—Gastrointestinal pain—Floxuridine—stomach cancer	0.000873	0.00824	CcSEcCtD
Tolmetin—Body temperature increased—Floxuridine—stomach cancer	0.000844	0.00797	CcSEcCtD
Tolmetin—Abdominal pain—Floxuridine—stomach cancer	0.000844	0.00797	CcSEcCtD
Tolmetin—Oedema—Mitomycin—stomach cancer	0.000837	0.00791	CcSEcCtD
Tolmetin—PTGS2—hematopoietic system—stomach cancer	0.000836	0.0173	CbGeAlD
Tolmetin—Thrombocytopenia—Mitomycin—stomach cancer	0.00082	0.00774	CcSEcCtD
Tolmetin—PTGS1—epithelium—stomach cancer	0.0008	0.0165	CbGeAlD
Tolmetin—Visual disturbance—Irinotecan—stomach cancer	0.000781	0.00737	CcSEcCtD
Tolmetin—Proteinuria—Capecitabine—stomach cancer	0.000776	0.00733	CcSEcCtD
Tolmetin—PTGS1—smooth muscle tissue—stomach cancer	0.00077	0.0159	CbGeAlD
Tolmetin—Protein urine present—Capecitabine—stomach cancer	0.000766	0.00723	CcSEcCtD
Tolmetin—Asthenia—Floxuridine—stomach cancer	0.000766	0.00723	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Irinotecan—stomach cancer	0.000764	0.00722	CcSEcCtD
Tolmetin—PTGS2—epithelium—stomach cancer	0.000764	0.0158	CbGeAlD
Tolmetin—Somnolence—Mitomycin—stomach cancer	0.000744	0.00703	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Irinotecan—stomach cancer	0.00074	0.00699	CcSEcCtD
Tolmetin—PTGS2—smooth muscle tissue—stomach cancer	0.000736	0.0152	CbGeAlD
Tolmetin—MPO—lymph node—stomach cancer	0.000732	0.0151	CbGeAlD
Tolmetin—Diarrhoea—Floxuridine—stomach cancer	0.00073	0.0069	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Fluorouracil—stomach cancer	0.000709	0.00669	CcSEcCtD
Tolmetin—Blood pressure increased—Docetaxel—stomach cancer	0.000705	0.00666	CcSEcCtD
Tolmetin—Blood pressure increased—Capecitabine—stomach cancer	0.000682	0.00644	CcSEcCtD
Tolmetin—PTGS2—pancreas—stomach cancer	0.000681	0.0141	CbGeAlD
Tolmetin—Vomiting—Floxuridine—stomach cancer	0.000678	0.00641	CcSEcCtD
Tolmetin—Headache—Floxuridine—stomach cancer	0.000668	0.00631	CcSEcCtD
Tolmetin—Body temperature increased—Mitomycin—stomach cancer	0.000662	0.00625	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—stomach cancer	0.000657	0.143	CrCbGaD
Tolmetin—Nausea—Floxuridine—stomach cancer	0.000634	0.00599	CcSEcCtD
Tolmetin—PTGS1—digestive system—stomach cancer	0.000608	0.0126	CbGeAlD
Tolmetin—Asthenia—Mitomycin—stomach cancer	0.000601	0.00567	CcSEcCtD
Tolmetin—PTGS2—lymphoid tissue—stomach cancer	0.000589	0.0122	CbGeAlD
Tolmetin—PTGS2—digestive system—stomach cancer	0.000581	0.012	CbGeAlD
Tolmetin—Weight decreased—Irinotecan—stomach cancer	0.000579	0.00546	CcSEcCtD
Tolmetin—Proteinuria—Methotrexate—stomach cancer	0.000578	0.00546	CcSEcCtD
Tolmetin—Diarrhoea—Mitomycin—stomach cancer	0.000573	0.00541	CcSEcCtD
Tolmetin—Protein urine present—Methotrexate—stomach cancer	0.00057	0.00538	CcSEcCtD
Tolmetin—Cardiac failure congestive—Docetaxel—stomach cancer	0.000564	0.00533	CcSEcCtD
Tolmetin—Renal failure—Irinotecan—stomach cancer	0.00056	0.00529	CcSEcCtD
Tolmetin—Stomatitis—Irinotecan—stomach cancer	0.000556	0.00525	CcSEcCtD
Tolmetin—Dizziness—Mitomycin—stomach cancer	0.000554	0.00523	CcSEcCtD
Tolmetin—Vascular purpura—Capecitabine—stomach cancer	0.000554	0.00523	CcSEcCtD
Tolmetin—Glossitis—Methotrexate—stomach cancer	0.000551	0.00521	CcSEcCtD
Tolmetin—Haemolytic anaemia—Capecitabine—stomach cancer	0.000549	0.00518	CcSEcCtD
Tolmetin—Visual disturbance—Docetaxel—stomach cancer	0.00054	0.0051	CcSEcCtD
Tolmetin—PTGS2—bone marrow—stomach cancer	0.000536	0.0111	CbGeAlD
Tolmetin—Vomiting—Mitomycin—stomach cancer	0.000532	0.00503	CcSEcCtD
Tolmetin—Stomatitis—Fluorouracil—stomach cancer	0.000532	0.00503	CcSEcCtD
Tolmetin—Urinary tract infection—Fluorouracil—stomach cancer	0.000531	0.00501	CcSEcCtD
Tolmetin—Headache—Mitomycin—stomach cancer	0.000525	0.00495	CcSEcCtD
Tolmetin—Glossitis—Epirubicin—stomach cancer	0.000516	0.00487	CcSEcCtD
Tolmetin—Epistaxis—Fluorouracil—stomach cancer	0.000515	0.00487	CcSEcCtD
Tolmetin—Purpura—Capecitabine—stomach cancer	0.000514	0.00485	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.000511	0.00483	CcSEcCtD
Tolmetin—Agranulocytosis—Fluorouracil—stomach cancer	0.00051	0.00481	CcSEcCtD
Tolmetin—PTGS1—endocrine gland—stomach cancer	0.000503	0.0104	CbGeAlD
Tolmetin—Nausea—Mitomycin—stomach cancer	0.000497	0.0047	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.000495	0.00468	CcSEcCtD
Tolmetin—Visual impairment—Irinotecan—stomach cancer	0.000493	0.00466	CcSEcCtD
Tolmetin—Ketorolac—PTGS2—stomach cancer	0.000488	0.106	CrCbGaD
Tolmetin—PTGS2—endocrine gland—stomach cancer	0.00048	0.00994	CbGeAlD
Tolmetin—Glossitis—Doxorubicin—stomach cancer	0.000477	0.00451	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—stomach cancer	0.000468	0.102	CrCbGaD
Tolmetin—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000461	0.00435	CcSEcCtD
Tolmetin—Indomethacin—PPARG—stomach cancer	0.000454	0.0991	CrCbGaD
Tolmetin—Blood urea increased—Epirubicin—stomach cancer	0.000449	0.00424	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000446	0.00421	CcSEcCtD
Tolmetin—Flatulence—Irinotecan—stomach cancer	0.000439	0.00415	CcSEcCtD
Tolmetin—Gastritis—Capecitabine—stomach cancer	0.000438	0.00414	CcSEcCtD
Tolmetin—PTGS2—liver—stomach cancer	0.000433	0.00896	CbGeAlD
Tolmetin—Lymphadenopathy—Methotrexate—stomach cancer	0.000432	0.00408	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—stomach cancer	0.000415	0.00392	CcSEcCtD
Tolmetin—Abdominal discomfort—Capecitabine—stomach cancer	0.00041	0.00388	CcSEcCtD
Tolmetin—Lymphadenopathy—Epirubicin—stomach cancer	0.000404	0.00382	CcSEcCtD
Tolmetin—Weight increased—Docetaxel—stomach cancer	0.000402	0.0038	CcSEcCtD
Tolmetin—Dysuria—Capecitabine—stomach cancer	0.0004	0.00378	CcSEcCtD
Tolmetin—Weight decreased—Docetaxel—stomach cancer	0.0004	0.00378	CcSEcCtD
Tolmetin—Lumiracoxib—PTGS2—stomach cancer	0.000398	0.0868	CrCbGaD
Tolmetin—Weight increased—Capecitabine—stomach cancer	0.000389	0.00368	CcSEcCtD
Tolmetin—Visual disturbance—Methotrexate—stomach cancer	0.000389	0.00367	CcSEcCtD
Tolmetin—Renal failure—Docetaxel—stomach cancer	0.000387	0.00366	CcSEcCtD
Tolmetin—Weight decreased—Capecitabine—stomach cancer	0.000387	0.00366	CcSEcCtD
Tolmetin—Vascular purpura—Epirubicin—stomach cancer	0.000386	0.00364	CcSEcCtD
Tolmetin—Stomatitis—Docetaxel—stomach cancer	0.000384	0.00363	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000381	0.0036	CcSEcCtD
Tolmetin—Cardiac failure congestive—Epirubicin—stomach cancer	0.00038	0.00359	CcSEcCtD
Tolmetin—Renal failure—Capecitabine—stomach cancer	0.000375	0.00354	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—stomach cancer	0.000374	0.00353	CcSEcCtD
Tolmetin—Stomatitis—Capecitabine—stomach cancer	0.000372	0.00351	CcSEcCtD
Tolmetin—Epistaxis—Docetaxel—stomach cancer	0.000372	0.00351	CcSEcCtD
Tolmetin—Urinary tract infection—Capecitabine—stomach cancer	0.000371	0.0035	CcSEcCtD
Tolmetin—Agranulocytosis—Docetaxel—stomach cancer	0.000368	0.00347	CcSEcCtD
Tolmetin—Haematuria—Capecitabine—stomach cancer	0.000364	0.00344	CcSEcCtD
Tolmetin—Oedema—Irinotecan—stomach cancer	0.000364	0.00343	CcSEcCtD
Tolmetin—Anaphylactic shock—Irinotecan—stomach cancer	0.000364	0.00343	CcSEcCtD
Tolmetin—Chest pain—Fluorouracil—stomach cancer	0.000363	0.00343	CcSEcCtD
Tolmetin—Fenbufen—PTGS2—stomach cancer	0.000362	0.0789	CrCbGaD
Tolmetin—Epistaxis—Capecitabine—stomach cancer	0.00036	0.0034	CcSEcCtD
Tolmetin—Purpura—Epirubicin—stomach cancer	0.000358	0.00338	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—stomach cancer	0.000357	0.00337	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000356	0.00337	CcSEcCtD
Tolmetin—Agranulocytosis—Capecitabine—stomach cancer	0.000356	0.00336	CcSEcCtD
Tolmetin—Thrombocytopenia—Irinotecan—stomach cancer	0.000356	0.00336	CcSEcCtD
Tolmetin—Hepatitis—Docetaxel—stomach cancer	0.000354	0.00334	CcSEcCtD
Tolmetin—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000352	0.00332	CcSEcCtD
Tolmetin—Oedema—Fluorouracil—stomach cancer	0.000348	0.00329	CcSEcCtD
Tolmetin—Anaphylactic shock—Fluorouracil—stomach cancer	0.000348	0.00329	CcSEcCtD
Tolmetin—PTGS1—lymph node—stomach cancer	0.000347	0.00719	CbGeAlD
Tolmetin—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000345	0.00326	CcSEcCtD
Tolmetin—Hepatitis—Capecitabine—stomach cancer	0.000343	0.00324	CcSEcCtD
Tolmetin—Thrombocytopenia—Fluorouracil—stomach cancer	0.000341	0.00322	CcSEcCtD
Tolmetin—Visual impairment—Docetaxel—stomach cancer	0.000341	0.00322	CcSEcCtD
Tolmetin—Erythema multiforme—Docetaxel—stomach cancer	0.000335	0.00316	CcSEcCtD
Tolmetin—PTGS2—lymph node—stomach cancer	0.000332	0.00687	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000332	0.00314	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—stomach cancer	0.000331	0.00313	CcSEcCtD
Tolmetin—Visual impairment—Capecitabine—stomach cancer	0.00033	0.00312	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00033	0.00312	CcSEcCtD
Tolmetin—Erythema multiforme—Capecitabine—stomach cancer	0.000324	0.00306	CcSEcCtD
Tolmetin—Somnolence—Irinotecan—stomach cancer	0.000323	0.00305	CcSEcCtD
Tolmetin—Dyspepsia—Irinotecan—stomach cancer	0.00032	0.00302	CcSEcCtD
Tolmetin—Tinnitus—Capecitabine—stomach cancer	0.000319	0.00302	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000319	0.00302	CcSEcCtD
Tolmetin—Constipation—Irinotecan—stomach cancer	0.000311	0.00294	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000311	0.00293	CcSEcCtD
Tolmetin—Somnolence—Fluorouracil—stomach cancer	0.00031	0.00292	CcSEcCtD
Tolmetin—Dyspepsia—Fluorouracil—stomach cancer	0.000307	0.0029	CcSEcCtD
Tolmetin—Abdominal discomfort—Methotrexate—stomach cancer	0.000305	0.00289	CcSEcCtD
Tolmetin—Gastritis—Epirubicin—stomach cancer	0.000305	0.00288	CcSEcCtD
Tolmetin—Suprofen—PTGS2—stomach cancer	0.000302	0.0658	CrCbGaD
Tolmetin—Dysuria—Methotrexate—stomach cancer	0.000298	0.00281	CcSEcCtD
Tolmetin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000297	0.00281	CcSEcCtD
Tolmetin—Flatulence—Capecitabine—stomach cancer	0.000294	0.00278	CcSEcCtD
Tolmetin—Abdominal pain—Irinotecan—stomach cancer	0.000287	0.00272	CcSEcCtD
Tolmetin—Body temperature increased—Irinotecan—stomach cancer	0.000287	0.00272	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000287	0.00272	CcSEcCtD
Tolmetin—Drowsiness—Methotrexate—stomach cancer	0.000284	0.00268	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—stomach cancer	0.000282	0.00267	CcSEcCtD
Tolmetin—Renal failure—Methotrexate—stomach cancer	0.000279	0.00264	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—stomach cancer	0.000279	0.00263	CcSEcCtD
Tolmetin—Stomatitis—Methotrexate—stomach cancer	0.000277	0.00262	CcSEcCtD
Tolmetin—Urticaria—Fluorouracil—stomach cancer	0.000277	0.00261	CcSEcCtD
Tolmetin—Body temperature increased—Fluorouracil—stomach cancer	0.000275	0.0026	CcSEcCtD
Tolmetin—Weight increased—Epirubicin—stomach cancer	0.000271	0.00256	CcSEcCtD
Tolmetin—Haematuria—Methotrexate—stomach cancer	0.000271	0.00256	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—stomach cancer	0.00027	0.00255	CcSEcCtD
Tolmetin—Epistaxis—Methotrexate—stomach cancer	0.000268	0.00253	CcSEcCtD
Tolmetin—Drowsiness—Epirubicin—stomach cancer	0.000266	0.00251	CcSEcCtD
Tolmetin—Agranulocytosis—Methotrexate—stomach cancer	0.000265	0.0025	CcSEcCtD
Tolmetin—Chest pain—Docetaxel—stomach cancer	0.000262	0.00248	CcSEcCtD
Tolmetin—Renal failure—Epirubicin—stomach cancer	0.000261	0.00247	CcSEcCtD
Tolmetin—Asthenia—Irinotecan—stomach cancer	0.000261	0.00246	CcSEcCtD
Tolmetin—Stomatitis—Epirubicin—stomach cancer	0.000259	0.00245	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—stomach cancer	0.000258	0.00244	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—stomach cancer	0.000258	0.00244	CcSEcCtD
Tolmetin—Hepatitis—Methotrexate—stomach cancer	0.000255	0.00241	CcSEcCtD
Tolmetin—Chest pain—Capecitabine—stomach cancer	0.000254	0.0024	CcSEcCtD
Tolmetin—Haematuria—Epirubicin—stomach cancer	0.000253	0.00239	CcSEcCtD
Tolmetin—Anaphylactic shock—Docetaxel—stomach cancer	0.000251	0.00237	CcSEcCtD
Tolmetin—Oedema—Docetaxel—stomach cancer	0.000251	0.00237	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—stomach cancer	0.000251	0.00237	CcSEcCtD
Tolmetin—Epistaxis—Epirubicin—stomach cancer	0.000251	0.00237	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—stomach cancer	0.00025	0.00236	CcSEcCtD
Tolmetin—Diarrhoea—Irinotecan—stomach cancer	0.000249	0.00235	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—stomach cancer	0.000248	0.00234	CcSEcCtD
Tolmetin—Thrombocytopenia—Docetaxel—stomach cancer	0.000246	0.00232	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—stomach cancer	0.000246	0.00232	CcSEcCtD
Tolmetin—Visual impairment—Methotrexate—stomach cancer	0.000246	0.00232	CcSEcCtD
Tolmetin—Oedema—Capecitabine—stomach cancer	0.000243	0.0023	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—stomach cancer	0.000242	0.00228	CcSEcCtD
Tolmetin—Erythema multiforme—Methotrexate—stomach cancer	0.000241	0.00228	CcSEcCtD
Tolmetin—Dizziness—Irinotecan—stomach cancer	0.00024	0.00227	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—stomach cancer	0.00024	0.00226	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—stomach cancer	0.000239	0.00226	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—stomach cancer	0.000239	0.00225	CcSEcCtD
Tolmetin—Diarrhoea—Fluorouracil—stomach cancer	0.000238	0.00225	CcSEcCtD
Tolmetin—Thrombocytopenia—Capecitabine—stomach cancer	0.000238	0.00225	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—stomach cancer	0.000238	0.00225	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—stomach cancer	0.000235	0.00222	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—stomach cancer	0.000232	0.00219	CcSEcCtD
Tolmetin—Vomiting—Irinotecan—stomach cancer	0.000231	0.00218	CcSEcCtD
Tolmetin—Dizziness—Fluorouracil—stomach cancer	0.00023	0.00218	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—stomach cancer	0.00023	0.00217	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—stomach cancer	0.00023	0.00217	CcSEcCtD
Tolmetin—Headache—Irinotecan—stomach cancer	0.000228	0.00215	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—stomach cancer	0.000226	0.00213	CcSEcCtD
Tolmetin—Somnolence—Docetaxel—stomach cancer	0.000223	0.00211	CcSEcCtD
Tolmetin—Tinnitus—Epirubicin—stomach cancer	0.000223	0.0021	CcSEcCtD
Tolmetin—Vomiting—Fluorouracil—stomach cancer	0.000221	0.00209	CcSEcCtD
Tolmetin—Dyspepsia—Docetaxel—stomach cancer	0.000221	0.00209	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—stomach cancer	0.000221	0.00209	CcSEcCtD
Tolmetin—Headache—Fluorouracil—stomach cancer	0.000218	0.00206	CcSEcCtD
Tolmetin—Nausea—Irinotecan—stomach cancer	0.000216	0.00204	CcSEcCtD
Tolmetin—Constipation—Docetaxel—stomach cancer	0.000215	0.00203	CcSEcCtD
Tolmetin—Dyspepsia—Capecitabine—stomach cancer	0.000214	0.00202	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—stomach cancer	0.000213	0.00201	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—stomach cancer	0.000209	0.00197	CcSEcCtD
Tolmetin—Constipation—Capecitabine—stomach cancer	0.000208	0.00197	CcSEcCtD
Tolmetin—Nausea—Fluorouracil—stomach cancer	0.000207	0.00195	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—stomach cancer	0.000206	0.00194	CcSEcCtD
Tolmetin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000206	0.00194	CcSEcCtD
Tolmetin—Flatulence—Epirubicin—stomach cancer	0.000205	0.00193	CcSEcCtD
Tolmetin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000199	0.00188	CcSEcCtD
Tolmetin—Abdominal pain—Docetaxel—stomach cancer	0.000199	0.00188	CcSEcCtD
Tolmetin—Body temperature increased—Docetaxel—stomach cancer	0.000199	0.00188	CcSEcCtD
Tolmetin—Urticaria—Capecitabine—stomach cancer	0.000193	0.00183	CcSEcCtD
Tolmetin—Body temperature increased—Capecitabine—stomach cancer	0.000192	0.00182	CcSEcCtD
Tolmetin—Abdominal pain—Capecitabine—stomach cancer	0.000192	0.00182	CcSEcCtD
Tolmetin—Indomethacin—PTGS2—stomach cancer	0.000192	0.0418	CrCbGaD
Tolmetin—Flatulence—Doxorubicin—stomach cancer	0.000189	0.00179	CcSEcCtD
Tolmetin—Chest pain—Methotrexate—stomach cancer	0.000189	0.00179	CcSEcCtD
Tolmetin—Anaphylactic shock—Methotrexate—stomach cancer	0.000181	0.00171	CcSEcCtD
Tolmetin—Asthenia—Docetaxel—stomach cancer	0.00018	0.0017	CcSEcCtD
Tolmetin—Thrombocytopenia—Methotrexate—stomach cancer	0.000177	0.00168	CcSEcCtD
Tolmetin—Chest pain—Epirubicin—stomach cancer	0.000177	0.00167	CcSEcCtD
Tolmetin—Asthenia—Capecitabine—stomach cancer	0.000175	0.00165	CcSEcCtD
Tolmetin—Diarrhoea—Docetaxel—stomach cancer	0.000172	0.00162	CcSEcCtD
Tolmetin—Indomethacin—ALB—stomach cancer	0.000171	0.0373	CrCbGaD
Tolmetin—Anaphylactic shock—Epirubicin—stomach cancer	0.00017	0.0016	CcSEcCtD
Tolmetin—Oedema—Epirubicin—stomach cancer	0.00017	0.0016	CcSEcCtD
Tolmetin—Diarrhoea—Capecitabine—stomach cancer	0.000167	0.00157	CcSEcCtD
Tolmetin—Dizziness—Docetaxel—stomach cancer	0.000166	0.00157	CcSEcCtD
Tolmetin—Thrombocytopenia—Epirubicin—stomach cancer	0.000166	0.00157	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—stomach cancer	0.000164	0.00155	CcSEcCtD
Tolmetin—Somnolence—Methotrexate—stomach cancer	0.000161	0.00152	CcSEcCtD
Tolmetin—Dizziness—Capecitabine—stomach cancer	0.000161	0.00152	CcSEcCtD
Tolmetin—Vomiting—Docetaxel—stomach cancer	0.00016	0.00151	CcSEcCtD
Tolmetin—Dyspepsia—Methotrexate—stomach cancer	0.000159	0.00151	CcSEcCtD
Tolmetin—Headache—Docetaxel—stomach cancer	0.000157	0.00149	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000157	0.00148	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—stomach cancer	0.000157	0.00148	CcSEcCtD
Tolmetin—Vomiting—Capecitabine—stomach cancer	0.000155	0.00146	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000154	0.00145	CcSEcCtD
Tolmetin—Headache—Capecitabine—stomach cancer	0.000152	0.00144	CcSEcCtD
Tolmetin—Somnolence—Epirubicin—stomach cancer	0.000151	0.00142	CcSEcCtD
Tolmetin—Nausea—Docetaxel—stomach cancer	0.000149	0.00141	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—stomach cancer	0.000149	0.00141	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000148	0.0014	CcSEcCtD
Tolmetin—Constipation—Epirubicin—stomach cancer	0.000145	0.00137	CcSEcCtD
Tolmetin—Nausea—Capecitabine—stomach cancer	0.000145	0.00137	CcSEcCtD
Tolmetin—Urticaria—Methotrexate—stomach cancer	0.000144	0.00136	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—stomach cancer	0.000143	0.00135	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—stomach cancer	0.000143	0.00135	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—stomach cancer	0.000139	0.00132	CcSEcCtD
Tolmetin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000139	0.00131	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—stomach cancer	0.000138	0.0013	CcSEcCtD
Tolmetin—Urticaria—Epirubicin—stomach cancer	0.000135	0.00127	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—stomach cancer	0.000134	0.00127	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—stomach cancer	0.000134	0.00127	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—stomach cancer	0.000134	0.00127	CcSEcCtD
Tolmetin—Asthenia—Methotrexate—stomach cancer	0.00013	0.00123	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000128	0.00121	CcSEcCtD
Tolmetin—Urticaria—Doxorubicin—stomach cancer	0.000125	0.00118	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—stomach cancer	0.000124	0.00117	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—stomach cancer	0.000124	0.00117	CcSEcCtD
Tolmetin—Diarrhoea—Methotrexate—stomach cancer	0.000124	0.00117	CcSEcCtD
Tolmetin—Asthenia—Epirubicin—stomach cancer	0.000122	0.00115	CcSEcCtD
Tolmetin—Dizziness—Methotrexate—stomach cancer	0.00012	0.00113	CcSEcCtD
Tolmetin—Diarrhoea—Epirubicin—stomach cancer	0.000116	0.0011	CcSEcCtD
Tolmetin—Vomiting—Methotrexate—stomach cancer	0.000115	0.00109	CcSEcCtD
Tolmetin—Headache—Methotrexate—stomach cancer	0.000114	0.00107	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—stomach cancer	0.000113	0.00106	CcSEcCtD
Tolmetin—Dizziness—Epirubicin—stomach cancer	0.000112	0.00106	CcSEcCtD
Tolmetin—Vomiting—Epirubicin—stomach cancer	0.000108	0.00102	CcSEcCtD
Tolmetin—Nausea—Methotrexate—stomach cancer	0.000108	0.00102	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—stomach cancer	0.000107	0.00101	CcSEcCtD
Tolmetin—Headache—Epirubicin—stomach cancer	0.000106	0.001	CcSEcCtD
Tolmetin—Dizziness—Doxorubicin—stomach cancer	0.000104	0.00098	CcSEcCtD
Tolmetin—Nausea—Epirubicin—stomach cancer	0.000101	0.000951	CcSEcCtD
Tolmetin—Vomiting—Doxorubicin—stomach cancer	9.97e-05	0.000942	CcSEcCtD
Tolmetin—Headache—Doxorubicin—stomach cancer	9.83e-05	0.000928	CcSEcCtD
Tolmetin—Nausea—Doxorubicin—stomach cancer	9.32e-05	0.00088	CcSEcCtD
Tolmetin—CXCL8—Signaling Pathways—FST—stomach cancer	4.25e-05	0.000349	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ADRB2—stomach cancer	4.23e-05	0.000347	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	4.23e-05	0.000347	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	4.19e-05	0.000344	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK3—stomach cancer	4.18e-05	0.000343	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HBEGF—stomach cancer	4.16e-05	0.000342	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA1—stomach cancer	4.15e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CKB—stomach cancer	4.15e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FBP1—stomach cancer	4.15e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NDUFA2—stomach cancer	4.15e-05	0.000341	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	4.11e-05	0.000338	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	4.1e-05	0.000337	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RGS2—stomach cancer	4.1e-05	0.000337	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GAST—stomach cancer	4.1e-05	0.000337	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—stomach cancer	4.06e-05	0.000334	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—stomach cancer	4.04e-05	0.000332	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	3.99e-05	0.000328	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—MAPK1—stomach cancer	3.97e-05	0.000327	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ALB—stomach cancer	3.96e-05	0.000326	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBP1—stomach cancer	3.94e-05	0.000324	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLIN2—stomach cancer	3.91e-05	0.000321	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	3.9e-05	0.000321	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGG—stomach cancer	3.89e-05	0.00032	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—BLVRB—stomach cancer	3.88e-05	0.000319	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PGLS—stomach cancer	3.88e-05	0.000319	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ADRB2—stomach cancer	3.84e-05	0.000316	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA2—stomach cancer	3.8e-05	0.000312	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—NOS3—stomach cancer	3.79e-05	0.000312	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PPP2R1A—stomach cancer	3.76e-05	0.000309	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKAA1—stomach cancer	3.74e-05	0.000308	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.74e-05	0.000308	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PGAM1—stomach cancer	3.7e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NT5E—stomach cancer	3.7e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPAP2A—stomach cancer	3.7e-05	0.000304	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RBP4—stomach cancer	3.62e-05	0.000297	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.56e-05	0.000292	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PLCE1—stomach cancer	3.53e-05	0.00029	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDH7A1—stomach cancer	3.53e-05	0.00029	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PGAM1—stomach cancer	3.51e-05	0.000288	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	3.49e-05	0.000287	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	3.48e-05	0.000286	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—stomach cancer	3.47e-05	0.000285	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—stomach cancer	3.39e-05	0.000279	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—UMPS—stomach cancer	3.39e-05	0.000278	CbGpPWpGaD
Tolmetin—PTGS2—Disease—WIF1—stomach cancer	3.35e-05	0.000275	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—stomach cancer	3.34e-05	0.000274	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	3.32e-05	0.000273	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	3.32e-05	0.000272	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA1—stomach cancer	3.3e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NDUFA2—stomach cancer	3.3e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CKB—stomach cancer	3.3e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FBP1—stomach cancer	3.3e-05	0.000271	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	3.25e-05	0.000267	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	3.22e-05	0.000265	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—stomach cancer	3.16e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PDHA1—stomach cancer	3.15e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ECHS1—stomach cancer	3.15e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL13—stomach cancer	3.15e-05	0.000259	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL18—stomach cancer	3.15e-05	0.000259	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HSPB1—stomach cancer	3.11e-05	0.000256	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGTR2—stomach cancer	3.11e-05	0.000256	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PLIN2—stomach cancer	3.1e-05	0.000255	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—F2R—stomach cancer	3.07e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BMP2—stomach cancer	3.07e-05	0.000253	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—stomach cancer	3.06e-05	0.000251	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—stomach cancer	3.05e-05	0.000251	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKR1C3—stomach cancer	3.02e-05	0.000249	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA2—stomach cancer	3.02e-05	0.000248	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.01e-05	0.000248	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HTR1A—stomach cancer	2.99e-05	0.000246	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RNF43—stomach cancer	2.98e-05	0.000245	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMP—stomach cancer	2.96e-05	0.000243	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FADS1—stomach cancer	2.96e-05	0.000243	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NT5E—stomach cancer	2.94e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PGAM1—stomach cancer	2.94e-05	0.000242	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS15—stomach cancer	2.94e-05	0.000241	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS21—stomach cancer	2.94e-05	0.000241	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PRKCB—stomach cancer	2.9e-05	0.000238	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ANXA1—stomach cancer	2.89e-05	0.000238	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.87e-05	0.000236	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.87e-05	0.000236	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	2.84e-05	0.000233	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDH7A1—stomach cancer	2.8e-05	0.00023	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PLCE1—stomach cancer	2.8e-05	0.00023	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRB1—stomach cancer	2.8e-05	0.00023	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—stomach cancer	2.78e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.78e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SREBF2—stomach cancer	2.77e-05	0.000228	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RORA—stomach cancer	2.74e-05	0.000225	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.71e-05	0.000223	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UMPS—stomach cancer	2.69e-05	0.000221	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RPS6—stomach cancer	2.67e-05	0.00022	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PRKCB—stomach cancer	2.63e-05	0.000216	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6ST—stomach cancer	2.62e-05	0.000215	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALDOB—stomach cancer	2.57e-05	0.000211	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—stomach cancer	2.55e-05	0.000209	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.51e-05	0.000206	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ECHS1—stomach cancer	2.5e-05	0.000205	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PDHA1—stomach cancer	2.5e-05	0.000205	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HBEGF—stomach cancer	2.46e-05	0.000202	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ALDOB—stomach cancer	2.43e-05	0.0002	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.42e-05	0.000199	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.41e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALOX5—stomach cancer	2.39e-05	0.000196	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL15—stomach cancer	2.39e-05	0.000196	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.37e-05	0.000195	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMP—stomach cancer	2.35e-05	0.000193	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FADS1—stomach cancer	2.35e-05	0.000193	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DPYD—stomach cancer	2.35e-05	0.000193	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NPM1—stomach cancer	2.34e-05	0.000192	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6R—stomach cancer	2.34e-05	0.000192	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—RHOA—stomach cancer	2.33e-05	0.000191	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.31e-05	0.00019	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRB2—stomach cancer	2.27e-05	0.000186	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RBP4—stomach cancer	2.26e-05	0.000186	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.26e-05	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.26e-05	0.000185	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	2.25e-05	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS26—stomach cancer	2.22e-05	0.000183	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PPP2R1A—stomach cancer	2.22e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPIA—stomach cancer	2.21e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SREBF2—stomach cancer	2.2e-05	0.000181	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RORA—stomach cancer	2.17e-05	0.000179	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.15e-05	0.000177	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—stomach cancer	2.13e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.13e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.13e-05	0.000175	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RHOA—stomach cancer	2.11e-05	0.000174	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—stomach cancer	2.08e-05	0.000171	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD4—stomach cancer	2.06e-05	0.00017	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP2A6—stomach cancer	2.05e-05	0.000169	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALDOB—stomach cancer	2.04e-05	0.000167	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKR1C3—stomach cancer	2e-05	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FYN—stomach cancer	1.96e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.96e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ENO1—stomach cancer	1.94e-05	0.00016	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.92e-05	0.000158	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.92e-05	0.000158	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.91e-05	0.000157	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX5—stomach cancer	1.89e-05	0.000156	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.89e-05	0.000156	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS19—stomach cancer	1.89e-05	0.000155	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKR1C3—stomach cancer	1.89e-05	0.000155	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DPYD—stomach cancer	1.86e-05	0.000153	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ENO1—stomach cancer	1.84e-05	0.000152	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR2—stomach cancer	1.84e-05	0.000151	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD44—stomach cancer	1.72e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.69e-05	0.000139	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS2—stomach cancer	1.68e-05	0.000138	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.67e-05	0.000138	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS6—stomach cancer	1.67e-05	0.000137	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—stomach cancer	1.65e-05	0.000135	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD44—stomach cancer	1.64e-05	0.000134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CAV1—stomach cancer	1.63e-05	0.000134	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APOA1—stomach cancer	1.63e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP2A6—stomach cancer	1.63e-05	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKR1C3—stomach cancer	1.58e-05	0.00013	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKCB—stomach cancer	1.55e-05	0.000128	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6ST—stomach cancer	1.55e-05	0.000127	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ENO1—stomach cancer	1.54e-05	0.000127	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HBEGF—stomach cancer	1.54e-05	0.000126	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.52e-05	0.000125	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—stomach cancer	1.49e-05	0.000122	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPP2R1A—stomach cancer	1.47e-05	0.000121	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—stomach cancer	1.44e-05	0.000118	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—stomach cancer	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HMOX1—stomach cancer	1.42e-05	0.000117	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PPP2R1A—stomach cancer	1.39e-05	0.000114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6R—stomach cancer	1.38e-05	0.000114	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD44—stomach cancer	1.37e-05	0.000113	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK1—stomach cancer	1.36e-05	0.000111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—stomach cancer	1.36e-05	0.000111	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMS—stomach cancer	1.34e-05	0.00011	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—stomach cancer	1.32e-05	0.000109	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—stomach cancer	1.3e-05	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SERPINE1—stomach cancer	1.29e-05	0.000106	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD4—stomach cancer	1.29e-05	0.000106	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—stomach cancer	1.28e-05	0.000105	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RHOA—stomach cancer	1.25e-05	0.000103	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ERCC2—stomach cancer	1.24e-05	0.000102	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOS3—stomach cancer	1.23e-05	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FYN—stomach cancer	1.23e-05	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERCC2—stomach cancer	1.18e-05	9.68e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—stomach cancer	1.18e-05	9.67e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—stomach cancer	1.17e-05	9.6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.16e-05	9.57e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—stomach cancer	1.16e-05	9.49e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR2—stomach cancer	1.15e-05	9.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—stomach cancer	1.14e-05	9.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HMOX1—stomach cancer	1.13e-05	9.26e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—stomach cancer	1.11e-05	9.1e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—stomach cancer	1.09e-05	8.94e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CAV1—stomach cancer	1.08e-05	8.86e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—APOA1—stomach cancer	1.08e-05	8.84e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—stomach cancer	1.07e-05	8.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMS—stomach cancer	1.06e-05	8.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS2—stomach cancer	1.05e-05	8.66e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—stomach cancer	1.05e-05	8.63e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—stomach cancer	1.04e-05	8.56e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CAV1—stomach cancer	1.02e-05	8.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—stomach cancer	1.02e-05	8.39e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APOA1—stomach cancer	1.02e-05	8.38e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUN—stomach cancer	1.02e-05	8.37e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—stomach cancer	9.91e-06	8.14e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—stomach cancer	9.87e-06	8.11e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ERCC2—stomach cancer	9.87e-06	8.11e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6ST—stomach cancer	9.68e-06	7.96e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK8—stomach cancer	9.64e-06	7.92e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—stomach cancer	9.47e-06	7.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—stomach cancer	9.31e-06	7.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—stomach cancer	9.28e-06	7.62e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—stomach cancer	8.9e-06	7.31e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—stomach cancer	8.81e-06	7.24e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6R—stomach cancer	8.64e-06	7.1e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CAV1—stomach cancer	8.56e-06	7.03e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—APOA1—stomach cancer	8.54e-06	7.02e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—stomach cancer	8.52e-06	7e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—stomach cancer	8.42e-06	6.92e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—stomach cancer	8.19e-06	6.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.17e-06	6.72e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NOS3—stomach cancer	8.15e-06	6.7e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SERPINE1—stomach cancer	8.09e-06	6.65e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK1—stomach cancer	8.01e-06	6.58e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—stomach cancer	8.01e-06	6.58e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RHOA—stomach cancer	7.8e-06	6.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS3—stomach cancer	7.72e-06	6.35e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—stomach cancer	7.56e-06	6.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—stomach cancer	7.52e-06	6.18e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—stomach cancer	7.45e-06	6.13e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—stomach cancer	7.23e-06	5.94e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—stomach cancer	6.95e-06	5.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—stomach cancer	6.76e-06	5.56e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—stomach cancer	6.72e-06	5.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—stomach cancer	6.69e-06	5.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NOS3—stomach cancer	6.47e-06	5.32e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—stomach cancer	6.43e-06	5.28e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—stomach cancer	6.18e-06	5.08e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—stomach cancer	6.15e-06	5.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—stomach cancer	5.51e-06	4.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—stomach cancer	5.26e-06	4.33e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—stomach cancer	5.12e-06	4.21e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK1—stomach cancer	5.01e-06	4.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—stomach cancer	5.01e-06	4.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—stomach cancer	4.73e-06	3.89e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—stomach cancer	4.59e-06	3.77e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—stomach cancer	4.35e-06	3.57e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—stomach cancer	4.02e-06	3.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—stomach cancer	3.85e-06	3.16e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—stomach cancer	3.64e-06	2.99e-05	CbGpPWpGaD
